Hisun Pharmaceutical announced that its controlling subsidiary, Hisun Animal Health, recently received the veterinary drug product approval number for telmisartan oral solution for cats, approved by the Ministry of Agriculture and Rural Affairs. The approval is valid from October 8, 2026 to October 7, 2031, with a specification of 30 milliliters to 0.12 grams. The product is used to treat proteinuria caused by chronic kidney disease in cats, and will help enrich the company's pet drug product line.
Zhejiang Hisun Pharmaceutical Co LtdControlling subsidiary Hisun Animal Health received veterinary drug approval for telmisartan oral solution for cats, enriching its pet drug product line.
